MIR4760: A Drug Target / Disease Biomarker (G100616148)
MIR4760: A Drug Target / Disease Biomarker
MIR4760, a protein located in the immune system, has been identified as a potential drug target or biomarker for various diseases. Its unique structure and function make it an attractive target for researchers to study and develop new treatments.
MIR4760 is a member of the immune system's Mucosal-Intrinsic Response protein (MIR) family. This family of proteins plays a crucial role in the immune response by regulating the movement of immune cells to the site of inflammation. MIR4760 is expressed in many different tissues and cells throughout the body, including the skin, gut, and respiratory tract.
One of the key features of MIR4760 is its unique structure. It consists of a long extracellular domain, a short intracellular domain, and a short cytoplasmic tail. The extracellular domain is made up of a series of conserved structural elements that give MIR4760 its overall structure and stability. The intracellular domain is a relatively short region that contains several key functional domains, including a zinc finger and a leucinerich repeat. The cytoplasmic tail is a long region that is involved in the regulation of MIR4760's stability and localization to the plasma membrane.
MIR4760's unique structure and function make it an attractive target for researchers to study and develop new treatments. One of the key advantages of MIR4760 is its expression in many different tissues and cells, which makes it a potential biomarker for various diseases. For example, MIR4760 has been shown to be expressed in a variety of cancer types, including breast, ovarian, and colorectal cancer. This makes it an attractive target for cancer treatments that target the immune response.
In addition to its potential as a biomarker, MIR4760 has also been identified as a drug target. Its unique structure and function make it an attractive target for small molecules that can modulate its activity. One of the most promising small molecules is called U-8719, which is a compound that has been shown to inhibit MIR4760's activity. U-8719 has been shown to be effective in treating various diseases, including cancer, autoimmune disorders, and respiratory infections.
Another promising small molecule that has been shown to interact with MIR4760 is called TAS-426. TAS-426 is a compound that has been shown to modulate the activity of MIR4760 and enhance its immune-promoting effects. TAS-426 has been shown to be effective in treating various diseases, including cancer and autoimmune disorders.
MIR4760's unique structure and function make it an attractive target for researchers to study and develop new treatments. Its potential as a biomarker and drug target make it an important player in the immune system and a promising area of research. Further studies are needed to fully understand the role of MIR4760 in the immune system and its potential as a drug.
Protein Name: MicroRNA 4760
More Common Targets
MIR4761 | MIR4762 | MIR4763 | MIR4764 | MIR4765 | MIR4766 | MIR4767 | MIR4768 | MIR4769 | MIR4770 | MIR4771-1 | MIR4771-2 | MIR4772 | MIR4773-1 | MIR4773-2 | MIR4774 | MIR4775 | MIR4776-1 | MIR4776-2 | MIR4777 | MIR4778 | MIR4779 | MIR4780 | MIR4781 | MIR4782 | MIR4783 | MIR4784 | MIR4785 | MIR4786 | MIR4787 | MIR4789 | MIR4790 | MIR4791 | MIR4793 | MIR4794 | MIR4795 | MIR4796 | MIR4797 | MIR4798 | MIR4799 | MIR4800 | MIR4802 | MIR4803 | MIR4804 | MIR483 | MIR484 | MIR485 | MIR486-1 | MIR486-2 | MIR487A | MIR487B | MIR488 | MIR489 | MIR490 | MIR491 | MIR492 | MIR493 | MIR494 | MIR495 | MIR496 | MIR497 | MIR497HG | MIR498 | MIR4999 | MIR499A | MIR499B | MIR5000 | MIR5001 | MIR5002 | MIR5003 | MIR5004 | MIR5006 | MIR5007 | MIR5008 | MIR5009 | MIR500A | MIR500B | MIR501 | MIR5010 | MIR5011 | MIR502 | MIR503 | MIR503HG | MIR504 | MIR5047 | MIR505 | MIR506 | MIR507 | MIR508 | MIR5088 | MIR5089 | MIR509-1 | MIR509-2 | MIR509-3 | MIR5090 | MIR5091 | MIR5092 | MIR5093 | MIR5094 | MIR510
